Showing 8,921 - 8,940 results of 9,271 for search 'ZX81~', query time: 1.22s Refine Results
  1. 8921

    Features of development and progression of colorectal cancer on a background of ulcerative colitis by I. L. Khalif, V. N. Kashnikov, A. V. Gusev, O. V. Golovenko, K. V. Bolikhov, L. L. Kapuller, A. N. Kuznetsov, A. V. Vasilchenko

    Published 2012-02-01
    “…Retrospective analysis of 65 cases with diagnosed CRC (2,1%) of 3154 patients with UC (treated in The State Scientific Centre of Coloproctology, Moscow, Russia from 1981 to 2010).Results. UC was diagnosed at the age of under 10 years in 5 patients (7,7%), from 10 to 19 years – in 16 (24,6%), 20–29 years – in 27 (41,5%), 30–39 years – in 4 (6,2%), 40–49 years – in 6 (9,2%), from 50 years and over – in 7 (10,8%). …”
    Get full text
    Article
  2. 8922

    Preoperative prediction of lymphovascular invasion and T-staging of rectal cancer via a dual-energy computed tomography iodine map: a feasibility study by Jinliang Zhang, Hui Qi, Chun Yang, Ling Liu, Yuxin Wang, Wei Li

    Published 2025-01-01
    “…The NIC values of PAT were significantly higher in the T3-4a group than in the T1-2 group in both the AP (4.034 ± 0.991 vs. 3.115 ± 0.581, P < 0.05) and the VP (5.481 ± 1.054 vs. 3.450 ± 0.980, P < 0.001). …”
    Get full text
    Article
  3. 8923
  4. 8924
  5. 8925
  6. 8926
  7. 8927
  8. 8928

    The effects of different cooking methods on some fatty acid composition in sea bass grown in marine, freshwater, and culture environments by Ali Şen, Gürkan Uçar

    “…Omega-3; (14.78; 9.19; 13.60; 9.89), (16.41; 9.35; 15.66; 10.34), (11.76; 9.73; 11.23; 9 ,41), omega-6; (18.52; 46.58, 12.36; 29.83), (22.53; 30.49; 12.86; 29.81), (18.19; 30.18; 18.30; 30 .34), saturated fat; (0.47; 0.51; 0.80; 0.38), (0.50; 0.58; 0.77; 0.50), (1.68; 1.21; 1.18; 2 .03), monounsaturated fat; (0.93; 1.29; 0.62; 0.97), (0.79; 1.35; 0.60; 1.16), (3.22; 2.73; 2.32; 4 .59), polyunsaturated fat; (0.70; 2.33; 0.51; 0.99), (0.93; 1.41; 0.56; 1.23), (2.45; 2.91; 1.72; 4 .83), ALA; (0.33; 1.31; 0.25; 0.63), (0.38; 0.27; 0.24; 0.57), (0.42; 0.42; 0.35; 0 ,28), EPA; (0.02; 0.01; 0.23; 0.02), (0.03; 0.01; 0.25; 0.03), (0.01; 0.01; 0.02; 0 .01), DHA; (5.72; 4.91; 10.64; 4.80), (8.26; 4.68; 12.36; 5.28), (5.47; 4.70; 5.18; 4 ,66).…”
    Get full text
    Article
  9. 8929

    Barriers to healthcare access among female youths in Mozambique: a mixed-effects and spatial analysis using DHS 2022/23 data by Habtu Kifle Negash, Hiwot Tezera Endale, Hailu Aragie, Winta Tesfaye, Mihret Getnet, Tseganesh Asefa, Yibeltal Yismaw Gela, Alebachew Ferede Zegeye

    Published 2025-02-01
    “…Results This study found that 49.10% (95% CI: 47.81%, 50.39%) of female youths reported barriers to healthcare access, primarily due to financial difficulties (40.69%) and distance (38.16%). …”
    Get full text
    Article
  10. 8930

    In Vitro Antioxidant, Anti-Inflammatory, and Digestive Enzymes Inhibition Activities of Hydro-Ethanolic Leaf and Bark Extracts of Psychotria densinervia (K. Krause) Verdc by Jean Romuald Mba, Djamila Zouheira, Hadidjatou Dairou, Fanta S. A. Yadang, Nfor Njini Gael, Lawrence Ayong, Jules-Roger Kuiate, Gabriel A. Agbor

    Published 2022-01-01
    “…Acarbose inhibited α-glucosidase (p<0.001) activity with IC50 (4.11 ± 3.47 μg/ml) lower than PHELE (24.41 ± 2.84 μg/ml) and PHEBE (38.81 ± 2.46 μg/ml). PHELE presented better antioxidant, anti-inflammatory, and enzyme inhibition activity than PHEBE.…”
    Get full text
    Article
  11. 8931
  12. 8932
  13. 8933
  14. 8934
  15. 8935
  16. 8936
  17. 8937

    Unravelling the role of secretory Immnuoglobulin-A in COVID-19: a multicentre study in nursing homes during the first wave by Rafael Bielza, Patricia Pérez, Nuria García, Laura Ballesteros-Sanabria, Rosa María Martínez, Azam Ghazi, Clara Hernando, María Victoria Rodríguez, Israel J. Thuissard, Cristina Andreu-Vázquez, José Manuel Bautista

    Published 2024-10-01
    “…Patients with severe disease and duration of symptoms > 10 days had higher levels of SIgA-S1 than those with mild disease (252 vs.192.6 U/mL; p = 0.012) or duration ≤ 10 days (270.5 vs. 208.1 U/mL; p = 0.043), respectively. No significant differences were observed in age, sex, CGA, duration of symptoms, disease severity, overall 30-day-mortality, or reinfection between “induced” and “non-induced” residents. …”
    Get full text
    Article
  18. 8938
  19. 8939
  20. 8940